Associate Professor, Pediatric Hematology-Oncology
Huntsman Cancer Institute/University of Utah Health
Luke Maese, D.O., received his Bachelor’s degree in Human Biology from the University of Kansas and then went on to receive his degree in osteopathic medicine from Kansas City University. He completed his Pediatric residency at UPMC Children’s Hospital of Pittsburgh and Pediatric Hematology/Oncology fellowship at the University of Utah and Primary Children’s Hospital. He joined the faculty of the University of Utah School of Medicine in the Division of Pediatric Hematology/Oncology in 2015 where he currently serves as an Associate Professor on the Clinical Track.
Dr. Maese’s focus includes clinical care for children with malignant hematopoietic disorders and cancer predisposition syndromes. He serves as director for both the pediatric Leukemia/Lymphoma and pediatric Cancer Genetics programs, the co-director of the Bone Marrow Failure Program, and the director of the Clinical Trial Research Enterprise within the division of pediatric hematology/oncology at Primary Children’s Hospital.
Dr. Maese’s interests in investigation are in pediatric leukemia and translating the genomics of cancer to the pediatric oncology clinic. His research efforts are focused on the study of cancer predisposition syndromes and clinical trials in pediatric acute lymphoblastic leukemia.
